Product Information
RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0834 per EA under NDC 65862047401. Its NADAC has been published 597 times since Nov 28, 2013.
FDA first approved this application on Jun 8, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862047401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA091604FDA Approved
6/8/2011
TE Code
AB
On Market Since
6/8/2011
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 597 times since Nov 28, 2013, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0834 per EA |
|---|---|
| All-time high | $0.2323 (Aug 13, 2014) |
| All-time low | $0.0626 (Jul 17, 2024) |
| 52-week high | $0.0989 |
| 52-week low | $0.0778 |
| Median price | $0.1156 |
| Average price | $0.1319 |
| Largest weekly change | +82.1% (Mar 20, 2024) |
| Weeks tracked | 597 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0834 per EA (NDC 65862047401), effective Aug 19, 2026.
How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 60.7%. It has been tracked across 597 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.0626 (Jul 17, 2024) to a high of $0.2323 (Aug 13, 2014), with a median of $0.1156 per EA.
Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RAMIPRIL 1.25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RAMIPRIL 1.25 MG CAPSULE?
RAMIPRIL 1.25 MG CAPSULE (NDC 65862047401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.